DK1200095T3 - Lægemiddel med protektiv virkning mod oxidativ-toksiske og især mod cardiotoksiske - Google Patents

Lægemiddel med protektiv virkning mod oxidativ-toksiske og især mod cardiotoksiske

Info

Publication number
DK1200095T3
DK1200095T3 DK00947960T DK00947960T DK1200095T3 DK 1200095 T3 DK1200095 T3 DK 1200095T3 DK 00947960 T DK00947960 T DK 00947960T DK 00947960 T DK00947960 T DK 00947960T DK 1200095 T3 DK1200095 T3 DK 1200095T3
Authority
DK
Denmark
Prior art keywords
toxic
drug
protective effect
cardiotoxic
oxidative
Prior art date
Application number
DK00947960T
Other languages
Danish (da)
English (en)
Inventor
Julius Gy Papp
Dirk Thormaehlen
Harald Waldeck
Zsuzsanna Rozsa
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of DK1200095T3 publication Critical patent/DK1200095T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00947960T 1999-07-13 2000-07-10 Lægemiddel med protektiv virkning mod oxidativ-toksiske og især mod cardiotoksiske DK1200095T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19932555A DE19932555A1 (de) 1999-07-13 1999-07-13 Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen

Publications (1)

Publication Number Publication Date
DK1200095T3 true DK1200095T3 (da) 2005-11-14

Family

ID=7914519

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00947960T DK1200095T3 (da) 1999-07-13 2000-07-10 Lægemiddel med protektiv virkning mod oxidativ-toksiske og især mod cardiotoksiske

Country Status (28)

Country Link
US (1) US6906059B2 (fr)
EP (1) EP1200095B1 (fr)
JP (1) JP4824235B2 (fr)
KR (1) KR100738940B1 (fr)
CN (1) CN1267099C (fr)
AR (1) AR024476A1 (fr)
AT (1) ATE306926T1 (fr)
AU (1) AU782733B2 (fr)
BR (1) BR0012442A (fr)
CA (1) CA2377904C (fr)
CZ (1) CZ299070B6 (fr)
DE (2) DE19932555A1 (fr)
DK (1) DK1200095T3 (fr)
ES (1) ES2246874T3 (fr)
HK (1) HK1049116B (fr)
HU (1) HUP0202424A3 (fr)
IL (2) IL147604A0 (fr)
MX (1) MXPA02000411A (fr)
NO (1) NO329558B1 (fr)
NZ (1) NZ517130A (fr)
PL (1) PL198723B1 (fr)
RU (1) RU2268727C2 (fr)
SK (1) SK286020B6 (fr)
TR (1) TR200200053T2 (fr)
TW (1) TWI280880B (fr)
UA (1) UA73134C2 (fr)
WO (1) WO2001003699A1 (fr)
ZA (1) ZA200200265B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
AR039352A1 (es) * 2001-05-18 2005-02-16 Solvay Pharm Gmbh Uso de un compuesto que tiene actividad inhibitoria combinada y concurrente con endopeptidasa neutra y metaloproteasa igs5.
PL224030B1 (pl) * 2001-09-10 2016-11-30 Tibotec Pharm Ltd Sposób syntezy heksahydrofuro [2,3-b] furan -3-olu oraz związki pośrednie stosowane w tym sposobie
RU2303041C2 (ru) * 2002-01-16 2007-07-20 Солвей Фармасьютикалс Б.В. Твердые соли бензазепиновых соединений и их применение при получении фармацевтических соединений
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7427611B2 (en) 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
ATE378053T1 (de) 2003-11-18 2007-11-15 Solvay Pharm Gmbh Pharmazeutische zusammensetzungen zur behandlung von nierenfunktionsstörungen
US20050267072A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20050288272A1 (en) * 2004-06-23 2005-12-29 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
EP1827448A1 (fr) 2004-12-15 2007-09-05 Solvay Pharmaceuticals GmbH Compositions pharmaceutiques comprenant des inhibiteurs nep, inhibiteurs du systeme de production de l'endotheline endogene et inhibiteurs de la reductase hmg coa
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
NZ571465A (en) * 2006-02-27 2011-09-30 Targeted Molecular Diagnostics Llc Compositions and methods for reducing cellular fat and for predicting cardiac toxicity and upon treatment with tyrosine kinase inhibitors
WO2007102171A2 (fr) * 2006-03-07 2007-09-13 Panacea Biotec Ltd Nouveaux sels de l'acide 1h-1-benzazépine-1-acétique, préparation de ceux-ci et composition pharmaceutique comprenant ceux-ci
US20070292503A1 (en) * 2006-06-16 2007-12-20 Gorissen Henricus R Oral pharmaceutical composition of poorly water-soluble active substance
US20070299054A1 (en) * 2006-06-22 2007-12-27 Rajesh Jain Oral pharmaceutical composition of a poorly water-soluble active agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel
AU1146099A (en) * 1997-09-18 1999-04-05 Janssen Pharmaceutica N.V. Fused imidazole derivatives for improving oral bioavailability of pharmaceuticalagents
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen

Also Published As

Publication number Publication date
AR024476A1 (es) 2002-10-02
PL353012A1 (en) 2003-10-06
ZA200200265B (en) 2003-03-26
KR100738940B1 (ko) 2007-07-12
NZ517130A (en) 2004-10-29
UA73134C2 (en) 2005-06-15
NO20020132L (no) 2002-03-12
HK1049116B (zh) 2006-12-08
IL147604A (en) 2006-12-31
CZ200252A3 (cs) 2002-08-14
JP2003504336A (ja) 2003-02-04
DE19932555A1 (de) 2001-01-18
AU782733B2 (en) 2005-08-25
HUP0202424A3 (en) 2003-03-28
NO20020132D0 (no) 2002-01-11
SK142002A3 (en) 2002-06-04
TR200200053T2 (tr) 2002-05-21
TWI280880B (en) 2007-05-11
EP1200095A1 (fr) 2002-05-02
HK1049116A1 (en) 2003-05-02
US6906059B2 (en) 2005-06-14
AU6157200A (en) 2001-01-30
CN1267099C (zh) 2006-08-02
CZ299070B6 (cs) 2008-04-16
DE50011388D1 (de) 2006-03-02
JP4824235B2 (ja) 2011-11-30
RU2268727C2 (ru) 2006-01-27
NO329558B1 (no) 2010-11-15
BR0012442A (pt) 2002-04-02
WO2001003699A1 (fr) 2001-01-18
CN1373666A (zh) 2002-10-09
MXPA02000411A (es) 2002-07-02
CA2377904C (fr) 2009-03-24
EP1200095B1 (fr) 2005-10-19
ES2246874T3 (es) 2006-03-01
IL147604A0 (en) 2002-08-14
US20030040512A1 (en) 2003-02-27
SK286020B6 (sk) 2008-01-07
ATE306926T1 (de) 2005-11-15
CA2377904A1 (fr) 2001-01-18
PL198723B1 (pl) 2008-07-31
KR20020019514A (ko) 2002-03-12
HUP0202424A2 (hu) 2002-11-28

Similar Documents

Publication Publication Date Title
DK1200095T3 (da) Lægemiddel med protektiv virkning mod oxidativ-toksiske og især mod cardiotoksiske
IS6411A (is) Kaspasa tálmar og notkun þeirra
NO20014096L (no) Fenyl- og pyridinylderivater
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
NO20022289L (no) Ny anvendelse og nye N-azabisykloamidderivater
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
DE60042805D1 (de) Spielvorrichtung und entsprechendes Aufzeichnungsmedium
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
DE60005810D1 (de) Fussstütze und möbelstück
NO20032753L (no) Forbindelse og anvendelse derav
EE200100373A (et) Bensoheterotsüklid ja nende kasutamine MEK inhibiitoritena
DK1251848T3 (da) Gyraseinhibitorer og anvendelse deraf
DE60141247D1 (de) Bandkassette und bandeinheit
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
NO20014702D0 (no) Diarylderivater og deres anvendelse som medikamenter
NO20011157L (no) Benzenderivater og farmasöytisk anvendelse derav
DE60143685D1 (de) Fördergerät und Aufzeichnungsgerät
DE69903143D1 (de) Chromanon und thiochromanon derivate
NO986174D0 (no) Triazinderivater og anvendelse derav
DE60015899D1 (de) Aufnahmevorrichtung und Aufnahmemedium
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
DK1231839T3 (da) Herbicid kombination med acylerede aminophenylsulfonylurinstoffer
DE60144529D1 (de) Bandkassette und bandeinheit
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf